Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)

Clinical trial NCT04381364 · UNKNOWN

Trial details

NCT number: NCT04381364
Sponsor: Ola Blennow, MD, PhD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Covid-19 Pneumonia, Viral Sars-CoV2

Start date: 2020-05-29
Primary completion: 2021-08-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.